Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid β peptides

BMC Neuroscience

Volumn 9, Issue , 2008, Pages

  Cao, Chuanhai ^a,b   Lin, Xiaoyang ^a   Wahi, Monika M ^a,c   Jackson, Eugene A ^a   Potter Jr , Huntington ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CYTOKINE; IMMUNOGLOBULIN; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; IMMUNOGLOBULIN G;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG SAFETY; EPITOPE MAPPING; FEMALE; GENE MUTATION; MOUSE; NONHUMAN; PROTEIN ANALYSIS; T LYMPHOCYTE; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; MUTATION;

ALZHEIMER VACCINES; AMYLOID BETA-PROTEIN; ANIMALS; CROSS REACTIONS; CYTOKINES; EPITOPE MAPPING; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED BALB C; MUTATION; T-LYMPHOCYTES;

EID: 41049108826     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-9-25     Document Type: Article

References (46)

1. Alzheimer's disease prevalence rates rise to more than five million in the United States http://www.alz.org/news_and_events_rates_rise.asp
2. Barghorn S Nimmrich V Striebinger A Krantz C Keller P Janson B Bahr M Schmidt M Bitner RS Harlan J Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease J Neurochem 2005, 95(3):834-847. 10.1111/j.1471-4159.2005.03407.x 16135089
3. Schenk D Barbour R Dunn W Gordon G Grajeda H Guido T Hu K Huang J Johnson-Wood K Khan K Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 1999, 400(6740):173-177. 10.1038/22124 10408445
4. Janus C Pearson J McLaurin J Mathews PM Jiang Y Schmidt SD Chishti MA Horne P Heslin D French J A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 2000, 408(6815):979-982. 10.1038/35050110 11140685
5. Morgan D Diamond DM Gottschall PE Ugen KE Dickey C Hardy J Duff K Jantzen P DiCarlo G Wilcock D A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 2000, 408(6815):982-985. 10.1038/35050116 11140686
6. Bard F Cannon C Barbour R Burke RL Games D Grajeda H Guido T Hu K Huang J Johnson-Wood K Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease Nat Med 2000, 6(8):916-919. 10.1038/ 78682 10932230
7. DeMattos RB Bales KR Cummins DJ Dodart JC Paul SM Holtzman DM Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc Natl Acad Sci USA 2001, 98(15):8850-8855. 37524 11438712 10.1073/ pnas.151261398
8. Yamamoto N Hasegawa K Matsuzaki K Naiki H Yanagisawa K Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid beta-protein J Neurochem 2004, 90(1):62-69. 10.1111/ j.1471-4159.2004.02459.x 15198667
9. Weiner HL Frenkel D Immunology and immunotherapy of Alzheimer's disease Nat Rev Immunol 2006, 6(5):404-416. 10.1038/nri1843 16639431
10. Kutzler MA Cao C Bai Y Dong H Choe PY Saulino V McLaughlin L Whelan A Choo AY Weiner DB Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice Vaccine 2006, 24(21):4630-4639. 10.1016/j.vaccine.2005.08.036 16157426
11. Bornebroek M De Jonghe C Haan J Kumar-Singh S Younkin S Roos R Van Broeckhoven C Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): Decreased plasma amyloid-beta 42 concentration Neurobiol Dis 2003, 14(3):619-623. 10.1016/j.nbd.2003.08.019 14678776
12. Van Nostrand WE Melchor JP Cho HS Greenberg SM Rebeck GW Pathogenic effects of D23N Iowa mutant amyloid beta -protein J Biol Chem 2001, 276(35):32860-32866. 10.1074/jbc.M104135200 11441013
13. Watson DJ Selkoe DJ Teplow DB Effects of the amyloid precursor protein Glu693→Gln 'Dutch' mutation on the production and stability of amyloid beta-protein Biochem J 1999, 340(Pt 3):703-709. 1220301 10359654 10.1042/0264-6021:3400703
14. Cras P van Harskamp F Hendriks L Ceuterick C van Duijn CM Stefanko SZ Hofman A Kros JM Van Broeckhoven C Martin JJ Presenile Alzheimer dementia characterized by amyloid angiopathy and large amyloid core type senile plaques in the APP 692Ala→Gly mutation Acta Neuropathol (Berl) 1998, 96(3):253-260. 10.1007/s004010050892
15. Popovic M Caballero-Bleda M Puelles L Popovic N Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease Int J Neurosci 1998, 95(3-4):203-236. 10.3109/ 00207459809003341 9777440
16. Clarkson AN Rahman R Appleton I Inflammation and autoimmunity as a central theme in neurodegenerative disorders: Fact or fiction? Curr Opin Investig Drugs 2004, 5(7):706-713. 15298065
17. Stills HF Jr Adjuvants and antibody production: Dispelling the myths associated with Freund's complete and other adjuvants Ilar J 2005, 46(3):280-293. 15953835
18. Gilman S Koller M Black RS Jenkins L Griffith SG Fox NC Eisner L Kirby L Rovira MB Forette F Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial Neurology 2005, 64(9):1553-1562. 10.1212/01.WNL.0000159740.16984.3C 15883316
19. Bayer AJ Bullock R Jones RW Wilkinson D Paterson KR Jenkins L Millais SB Donoghue S Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD Neurology 2005, 64(1):94-101. 15642910
20. Orgogozo JM Gilman S Dartigues JF Laurent B Puel M Kirby LC Jouanny P Dubois B Eisner L Flitman S Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 2003, 61(1):46-54. 12847155
21. Nicoll JA Wilkinson D Holmes C Steart P Markham H Weller RO Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: A case report Nat Med 2003, 9(4):448-452. 10.1038/ nm840 12640446
22. Hock C Konietzko U Streffer JR Tracy J Signorell A Muller-Tillmanns B Lemke U Henke K Moritz E Garcia E Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease Neuron 2003, 38(4):547-554. 10.1016/S0896-6273(03)00294-0 12765607
23. Cribbs DH Ghochikyan A Vasilevko V Tran M Petrushina I Sadzikava N Babikyan D Kesslak P Kieber-Emmons T Cotman CW Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid Int Immunol 2003, 15(4):505-514. 1483061 12663680 10.1093/intimm/dxg049
24. Spickler AR Roth JA Adjuvants in veterinary vaccines: Modes of action and adverse effects J Vet Intern Med 2003, 17(3):273-281. 10.1892/ 0891-6640(2003)017<0273:AIVVMO>2.3.CO;2 12774966
25. Ethell DW Shippy D Cao C Cracchiolo JR Runfeldt M Blake B Arendash GW A[beta]-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice Neurobiology of Disease 2006, 23(2):351-361. 16733088
26. Greenwood DL Sentry JW Gastritis in neonatal BALB/cCrSlc mice induced by immunization without adjuvant can be transferred to syngeneic nu/nu recipients Scand J Immunol 2006, 63(1):50-58. 10.1111/ j.1365-3083.2005.01712.x 16398701
27. Ferrer I Boada Rovira M Sanchez Guerra ML Rey MJ Costa-Jussa F Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease Brain Pathol 2004, 14(1):11-20. 14997933
28. Pfeifer M Boncristiano S Bondolfi L Stalder A Deller T Staufenbiel M Mathews PM Jucker M Cerebral hemorrhage after passive anti-Abeta immunotherapy Science 2002, 298(5597):1379. 10.1126/science.1078259 12434053
29. Wilcock DM Jantzen PT Li Q Morgan D Gordon MN Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid Neuroscience 2007, 144(3):950-960. 1857306 17137722 10.1016/ j.neuroscience.2006.10.020
30. Wilcock DM Rojiani A Rosenthal A Subbarao S Freeman MJ Gordon MN Morgan D Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage J Neuroinflammation 2004, 1(1):24. 539292 15588287 10.1186/1742-2094-1-24
31. Sigma Aldrich MPL®+TDM adjuvant system product information St. Louis, MO: Corixa Corporation 2003:1-2. http://www.sigmaaldrich.com/ sigma/datasheet/m6536dat.pdf
32. De Becker G Moulin V Pajak B Bruck C Francotte M Thiriart C Urbain J Moser M The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells Int Immunol 2000, 12(6):807-815. 10.1093/intimm/ 12.6.807 10837408
33. Ulrich JT Myers KR Monophosphoryl lipid A as an adjuvant Vaccine design: The subunit and adjuvant approach New York: Plenum Press Powel MFaN, MJ 1995:495.
34. Carrera MR Ashley JA Wirsching P Koob GF Janda KD A second-generation vaccine protects against the psychoactive effects of cocaine Proc Natl Acad Sci USA 2001, 98(4):1988-1992. 29369 11172063 10.1073/pnas.041610998
35. Toellner KM Luther SA Sze DM Choy RK Taylor DR MacLennan IC Acha-Orbea H T helper 1 (Th1) and Th2 characteristics start to develop during T cell priming and are associated with an immediate ability to induce immunoglobulin class switching J Exp Med 1998, 187(8):1193-1204. 10.1084/ jem.187.8.1193 9547331
36. Yu YYL Myers NB Hilbert CM Harris MR Balendiran GK Hansen TH Definition and transfer of a serological epitope specific for peptide-empty forms of MHC class I Int Immunol 1999, 11(12):1897-1906. 10.1093/intimm/ 11.12.1897 10590255
37. Brunel FM Zwick MB Cardoso RMF Nelson JD Wilson IA Burton DR Dawson PE Structure-Function Analysis of the Epitope for 4E10, a Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody J Virol 2006, 80(4):1680-1687. 1367132 16439525 10.1128/JVI.80.4.1680-1687.2006
38. Monsonego A Maron R Zota V Selkoe DJ Weiner HL Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease Proc Natl Acad Sci USA 2001, 98(18):10273-10278. 56951 11517335 10.1073/ pnas.191118298
39. The Jackson Laboratory JAX Ready Strain BALB/cJ Bar Harbor, ME: The Jackson Laboratory 2006 http://jaxmice.jax.org/literature/factsheet/ JAXstrains_BALBC.pdf
40. Cohen S Dovrat S Sarid R Huberman E Salzberg S JAK-STAT signaling involved in phorbol 12-myristate 13-acetate- and dimethyl sulfoxide-induced 2′-5′ oligoadenylate synthetase expression in human HL-60 leukemia cells Leuk Res 2005, 29(8):923-931. 10.1016/ j.leukres.2005.01.015 15978943
41. Heckert RA Elankumaran S Oshop GL Vakharia VN A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization Vet Immunol Immunopathol 2002, 89(1-2):67-81. 10.1016/ S0165-2427(02)00186-1 12208052
42. Pestronk A Teoh R Sims C Drachman DB Effects of dimethyl sulfoxide on humoral immune responses to acetylcholine receptors in the rat Clin Immunol Immunopathol 1985, 37(2):172-178. 10.1016/0090-1229(85)90148-5 3876185
43. Xing L Remick DG Mechanisms of dimethyl sulfoxide augmentation of IL-1 beta production J Immunol 2005, 174(10):6195-6202. 15879116
44. Gahtan E Overmier JB Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli Neurosci Biobehav Rev 1999, 23(5):615-633. 10.1016/S0149-7634(98)00058-X 10392655
45. Information and background on the HLA peptide motif searches http://www-bimas.cit.nih.gov/molbio/hla_bind/hla_motif_search_info.html
46. Nilsson LN Arendash GW Leighty RE Costa DA Low MA Garcia MF Cracciolo JR Rojiani A Wu X Bales KR Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation Neurobiol Aging 2004, 25(9):1153-1167. 10.1016/j.neurobiolaging.2003.12.011 15312961